Free Trial

Jasper Therapeutics (JSPRW) Competitors

Jasper Therapeutics logo
$0.10 +0.00 (+4.21%)
As of 11:22 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

JSPRW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Jasper Therapeutics stock or one of its competitors? The main competitors of Jasper Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Jasper Therapeutics vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Jasper Therapeutics (NASDAQ:JSPRW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Jasper Therapeutics N/A N/A N/A

In the previous week, Jasper Therapeutics had 6 more articles in the media than 180 Life Sciences. MarketBeat recorded 6 mentions for Jasper Therapeutics and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.00 beat Jasper Therapeutics' score of -0.14 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Neutral
Jasper Therapeutics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Jasper TherapeuticsN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Jasper Therapeutics tied by winning 1 of the 2 factors compared between the two stocks.

Get Jasper Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JSPRW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JSPRW vs. The Competition

MetricJasper TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$129.06M$5.59B$9.02B
Dividend YieldN/A3.74%5.25%4.03%
P/E RatioN/A3.4027.5220.21
Price / SalesN/A4,290.93414.66171.34
Price / CashN/A13.1937.0657.97
Price / BookN/A41.698.095.62
Net IncomeN/A-$92.15M$3.17B$248.50M
7 Day Performance-7.47%1.30%3.48%4.82%
1 Month Performance-8.77%3.30%3.69%7.34%
1 Year Performance-48.00%175.80%33.83%21.46%

Jasper Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JSPRW
Jasper Therapeutics
N/A$0.10
+4.2%
N/A-56.2%$0.00N/A0.0020
ATNFW
180 Life Sciences
N/A$0.01
-1.2%
N/A-31.4%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-85.2%$0.00N/A0.002
AIMDW
Ainos
N/A$0.12
-7.7%
N/A+159.1%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-46.8%$0.00$585.60M0.004Positive News
Gap Up
AMPE
Ampio Pharmaceuticals
0.154 of 5 stars
$0.00
-96.3%
N/A-97.3%$0.00N/A0.0020Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/A-76.6%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/A+213.1%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
-2.0%
N/AN/A$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.06
-17.1%
N/A-70.5%$0.00N/A0.008News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:JSPRW) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners